{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T22:10:15Z","timestamp":1684102215369},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1007\/bf02752293","type":"journal-article","created":{"date-parts":[[2007,11,21]],"date-time":"2007-11-21T12:26:29Z","timestamp":1195647989000},"page":"181-191","source":"Crossref","is-referenced-by-count":2,"title":["Fragile X syndrome"],"prefix":"10.1007","volume":"65","author":[{"given":"John P.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02752293_CR1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ajmg.1320230151","volume":"23","author":"TP Webb","year":"1986","unstructured":"Webb TP, Bundey SE, Thake AI, Todd J. Population incidence and segregation rations in the Martin-Bell syndrome.Am J Med Genet 1986; 23: 573\u2013580.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.98.2.297","volume":"98","author":"AAP Committee on Genetics","year":"1996","unstructured":"AAP Committee on Genetics. Health supervision for children with fragile X syndrome.Pediatrics 1996; 98: 297\u2013300.","journal-title":"Pediatrics"},{"key":"BF02752293_CR3","first-page":"1006","volume":"57","author":"F Rousseau","year":"1995","unstructured":"Rousseau F, Rouillard P, More ML, Khandjian EW, Morgan K. Prevalence of carriers or premutation-size alleles of the EMRI gene-and implications for the population genetics of the fragile X syndrome.Am J Hum Genet 1995; 57: 1006\u20131018.","journal-title":"Am J Hum Genet"},{"key":"BF02752293_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jnnp.6.3-4.154","volume":"6","author":"JP Martin","year":"1943","unstructured":"Martin JP, Bell JJ Neurol Psych 1943; 6: 154\u2013157.","journal-title":"J Neurol Psych"},{"key":"BF02752293_CR5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1542\/peds.97.1.122","volume":"97","author":"RJ Hagerman","year":"1995","unstructured":"Hagerman RJ, Lugenbeel K, McLean SD, Taylor A. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range.Pediatrics 1995; 97: 122\u2013125.","journal-title":"Pediatrics"},{"key":"BF02752293_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/1043-4682(95)90009-8","volume":"6","author":"DL Nelson","year":"1995","unstructured":"Nelson DL. The fragile X syndromesSemin Cell Biol 1995; 6: 5\u201311.","journal-title":"Semin Cell Biol"},{"key":"BF02752293_CR7","first-page":"293","volume":"1271","author":"AV Lannery","year":"1995","unstructured":"Lannery AV, Hirst MC, Knight SJ, et al. The fragile X syndrome.Biochem Biophys Acta 1995; 1271: 293\u2013303.","journal-title":"Biochem Biophys Acta"},{"key":"BF02752293_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1203\/00006450-199511000-00001","volume":"38","author":"BA Oostra","year":"1995","unstructured":"Oostra BA, Halley DJ. Complex behaviour of simple repeats: the fragile X syndrome.Pediatr Res 1995; 38: 629\u2013637.","journal-title":"Pediatr Res"},{"issue":"7","key":"BF02752293_CR9","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1128\/MCB.16.7.3825","volume":"16","author":"MC Siomi","year":"1996","unstructured":"Siomi MC, Zhang Y, Siomi H,et al. Specific sequences in the fragile X syndrome protein FMR 1 and FXR proteins mediate their binding to 60S ribosomal subunits and the ineractions among them.Mol Cell Biol 1996; 16 (7): 3825\u20133832.","journal-title":"Mol Cell Biol"},{"key":"BF02752293_CR10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/bies.950171107","volume":"17","author":"BA Oostra","year":"1995","unstructured":"Oostra BA, Willems PJ. A fragile geneBioessays 1995; 17: 941\u2013947.","journal-title":"Bioessays"},{"key":"BF02752293_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00687814","volume":"67","author":"RD Rudelli","year":"1985","unstructured":"Rudelli RD, Brwon WT, Wisniewski Ket al. Adult fragile X syndrome. Cliniconeuropathologic findings.Acta Neuropathol 1985; 67: 289\u2013295.","journal-title":"Acta Neuropathol"},{"key":"BF02752293_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ajmg.1320410306","volume":"41","author":"VJ Hinton","year":"1991","unstructured":"Hinton VJ, Brown Wisniewski K, Rudell RD. Analysis of neocortex in three males with fragile X syndrome.Am J Med Genet 1991; 41: 289\u2013294.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1212\/WNL.44.7.1317","volume":"44","author":"AL Reiss","year":"1994","unstructured":"Reiss AL, Lee J, Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe.Neurology 1994; 44: 1317\u20131324.","journal-title":"Neurology"},{"key":"BF02752293_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1195-331","volume":"11","author":"AL Reiss","year":"1995","unstructured":"Reiss AL, Freund LS, Baumgardner TL, et al. Contribution of the FMR-1 gene mutation to human intellectual dysfunction.Nat Genet 1995b; 11: 331\u2013334.","journal-title":"Nat Genet"},{"key":"BF02752293_CR15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/WNL.44.2.214","volume":"44","author":"E Courchesne","year":"1994","unstructured":"Courchesne E, Townsend J, Saitoh O. The brain in infantile autism: posterior fossa structures are abnormal.Neurology 1994; 44: 214\u2013223.","journal-title":"Neurology"},{"key":"BF02752293_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0004.1991.tb03041.x","volume":"39","author":"MG Butler","year":"1991","unstructured":"Butler MG, Mangrum T, Gupta R, Singh DN. A 15-item checklist for screening mentally retarded males for the fragile X syndrome.Clin Genet 1991; 39: 347\u2013354.","journal-title":"Clin Genet"},{"key":"BF02752293_CR17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajmg.1320380220","volume":"38","author":"G Merlin","year":"1991","unstructured":"Merlin G, Butler C, Allen Andrew,et al. Anthropometric comparison of mentally retarded males with and without the fragile X syndrome.Am J Med Genet 1991; 38: 260\u2013268.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ajmg.1320380219","volume":"38","author":"S Laing","year":"1991","unstructured":"Laing S, Partington M, Robinson H, Turner G. Clinical screening score for the fragile X (Martin-Bell) syndrome.Am J Med Genet 1991; 38: 256\u2013259.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-3476(96)70130-0","volume":"129","author":"CA Giangreco","year":"1996","unstructured":"Giangreco CA, Steele MW, Aston C,et al. A simplified six-item checklist for screening fragile X syndrome in the pediatric population.J Pediatr 1996; 129: 611\u2013614.","journal-title":"J Pediatr"},{"key":"BF02752293_CR20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajmg.1320500211","volume":"50","author":"B Maes","year":"1994","unstructured":"Maes B, Fryns JP, Van Walleghem M, Van den Berghe. Cognitive functioning and infomation processing of adult mentally retarded men with fragile X syndrome. Am J Med Genet 1994; 50: 190\u2013200.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ajmg.1320510412","volume":"51","author":"DA Hay","year":"1994","unstructured":"Hay DA. Does IQ decline with age in fragile-X? A Methodological Critique.Am J Med Genet 1994; 51: 358\u2013363.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-3223(90)90652-I","volume":"27","author":"AL Reiss","year":"1990","unstructured":"Reiss AL, Freund L. Fragile X Syndrome.Biol Psychiatry 1990; 27: 223\u2013240.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"BF02752293_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00001163-199401000-00006","volume":"6","author":"L Freund","year":"1994","unstructured":"Freund L. Diagnosis and developmental issues for young children with fragile X syndrome.Infants and Young Children 1994; 6 (3): 34\u201345.","journal-title":"Infants and Young Children"},{"key":"BF02752293_CR24","first-page":"245","volume":"4","author":"B Maes","year":"1993","unstructured":"Maes B, Fryns JP, Van Walleghen M, Van Den Berghe H. Fragile X syndrome and autism: a prevalent association or a misinterpreted connection.Genet. Couns 1993; 4: 245\u2013263.","journal-title":"Genet. Couns"},{"key":"BF02752293_CR25","first-page":"1236","volume":"147","author":"C Hull","year":"1993","unstructured":"Hull C, Hagerman RJ. A study of the physical, behavioural and medical phenotype, including anthropometric measures, of females with fragile X syndrome.AJDC 1993; 147: 1236\u20131241.","journal-title":"AJDC"},{"key":"BF02752293_CR26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.1994.03510310037035","volume":"271","author":"AK Taylor","year":"1994","unstructured":"Taylor AK, Safanda JF, Fall MZet al. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.JAMA 1994; 271: 507\u2013514.","journal-title":"JAMA"},{"key":"BF02752293_CR27","first-page":"1025","volume":"58","author":"BB deVries","year":"1996","unstructured":"deVries BB, Wiegers AM, Smits APet al. Mental status of females with an FMRI gene full mutation.Am J Hum Genet 1996; 58: 1025\u201332.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"BF02752293_CR28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00004583-199402000-00015","volume":"33","author":"MB Dorn","year":"1994","unstructured":"Dorn MB, Mazzoco MM, Hagerman RJ. Behavioral and psychiatric disorders in adult male carriers of fragile X.J Am Acad Child Adolesc Psychiatry 1994; 33 (2): 256\u2013264.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF02752293_CR29","unstructured":"Dykens EM, Hodapp RM, Leckman JF. Behaviour and Development in fragile X syndrome.Dev Clinical Psychol and Psych 28."},{"key":"BF02752293_CR30","unstructured":"Stackhause TM. Sensory integration concepts and fragile X syndrome. Teaching materials from the national fragile X association. Denver, CO, USA."},{"key":"BF02752293_CR31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/peds.87.4.519","volume":"87","author":"RA Barkley","year":"1991","unstructured":"Barkley RA, DuPaul GJ, McMurry MB. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate.Pediatrics 1991; 87: 519\u2013531.","journal-title":"Pediatrics"},{"key":"BF02752293_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ajmg.1320300138","volume":"30","author":"RJ Hagerman","year":"1988","unstructured":"Hagerman RJ, Murphy M, Wittenberger M. A controlled trial of stimulant medication in children with fragile X syndromeAm J Med Genet 1988; 30: 377\u2013392.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0009-9236(95)90233-3","volume":"57","author":"M Berkovitch","year":"1995","unstructured":"Berkovitch M, Pope E, Phillips J, Koren G. Pemoline-associated fulminant liver failure: testing the evidence for causation.Clin Pharmacol Ther 1995; 57: 696\u2013698.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02752293_CR34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","volume":"95","author":"HS Singer","year":"1995","unstructured":"Singer HS, Brown SS, Quaskey LAet al. The treatment of attention deficit hyper-activity disorder in Tourette's syndrome a double-blind placebo-controlled study with clonidine and desipramine.Pediatrics 1995; 95: 74\u201382.","journal-title":"Pediatrics"},{"key":"BF02752293_CR35","first-page":"831","volume":"30","author":"DK Hilton","year":"1991","unstructured":"Hilton DK, Martin CA, Heffron WMet al. Imipramine treatment of ADHD in a fragile X child.J Am Acad Child Adolesc Psychiatry 1991; 30: 831\u2013834.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF02752293_CR36","first-page":"336","volume":"8","author":"RJ Hagerman","year":"1995","unstructured":"Hagerman RJ, Riddle JE, Roberts LSet al. A survey of the efficacy of clonidine in fragile X syndrome.Dev Brain Dysf 1995; 8: 336\u2013344.","journal-title":"Dev Brain Dysf"},{"key":"BF02752293_CR37","first-page":"155","volume":"7","author":"RJ Hagerman","year":"1994","unstructured":"Hagerman RJ, Fulton MJ, Leaman A,et al. A survey of fluoxetine therapy in fragile X syndrome.Dev Brain Dysf 1994; 7: 155\u2013164.","journal-title":"Dev Brain Dysf"},{"key":"BF02752293_CR38","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ajmg.1320440529","volume":"44","author":"CM Strom","year":"1992","unstructured":"Strom CM, Brusca RM, Pizzi WJ. Doubleblind, placebo-controlled crossover study of folic acid for the treatment of fragile X syndrome.Am J Med Genet 1992; 44: 676\u2013682.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR39","volume-title":"Child and Adolescent Clinical Psychopharmacology","author":"WH Green","year":"1995","unstructured":"Green WH.Child and Adolescent Clinical Psychopharmacology, 2nd ed. 1995. Williams and Williams, Baltimore.","edition":"2nd ed."},{"key":"BF02752293_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1056-4993(18)30454-1","volume":"4","author":"T Spencer","year":"1995","unstructured":"Spencer T, Wilens T, Biederman J. Psychotropic medication for children and adolesents.Child and Adolescent Psychiatric Clinics of North America 1995; 4: 97\u2013121.","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"key":"BF02752293_CR41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ajmg.1320510436","volume":"51","author":"RJ Hagerman","year":"1994","unstructured":"Hagerman RJ, Wilson P, Staley LWet al. Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR-1 testing.Am J Med Genet 1994; 51: 474\u2013481.","journal-title":"Am J Med Genet"},{"key":"BF02752293_CR42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(95)90979-6","volume":"345","author":"R Willemsen","year":"1995","unstructured":"Willemsen R, Mohkamising S, De Vries B,et al. Rapid antibody test for fragile X syndrome.Lancet 1995; 345: 1147\u20131148.","journal-title":"Lancet"},{"key":"BF02752293_CR43","volume-title":"Fragile X Syndrome: Diagnosis, Treatment, and Research","author":"RJ Hagerman","year":"1996","unstructured":"Hagerman RJ, Cronister A.Fragile X Syndrome: Diagnosis, Treatment, and Research Baltimore Johns Hopkins University Press, 1996."},{"key":"BF02752293_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/088307389701200101","volume":"12","author":"BL Maria","year":"1997","unstructured":"Maria BL, Medina CD, Karin BNet al. Gene therapy for neurological disease: benchtop discoveries to bedside applications. 1. The Bench.J Child Neurol 1997; 12: 1\u201312.","journal-title":"J Child Neurol"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02752293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02752293\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02752293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T21:44:26Z","timestamp":1684100666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02752293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BF02752293"],"URL":"https:\/\/doi.org\/10.1007\/bf02752293","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}